COMPASS: A Group ACT Program for Cancer Patients Treated at UCSF

CompletedOBSERVATIONAL
Enrollment

129

Participants

Timeline

Start Date

March 24, 2020

Primary Completion Date

December 14, 2020

Study Completion Date

December 14, 2020

Conditions
Cancer
Interventions
BEHAVIORAL

Acceptance and Commitment Therapy

Seven group sessions

OTHER

Questionnaires

Outcomes measured include anxiety, depression, fear of recurrence, psychological flexibility, mindfulness; values based living, and quality of life. Participants completed surveys at 4 time points, pre and post, and two follow-up time points.

Trial Locations (1)

94143

University of California, San Francisco, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT04636346 - COMPASS: A Group ACT Program for Cancer Patients Treated at UCSF | Biotech Hunter | Biotech Hunter